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Abstract
The aims of this investigation were: (1) to compare residual stone-fragment (RSF) detection rates of ultra-low dose computed
tomography (ULD-CT) and abdominal plain film (KUB) in urolithiasis patients undergoing shock-wave lithotripsy (SWL),
and (2) to evaluate the downstream sequelae of utilizing these two disparate imaging pathways of differing diagnostic fidelity.
A retrospective chart-review of patients undergoing SWL at two high-volume surgical centers was undertaken (2013–2016).
RSF diagnostic rates of ULD-CT and KUB were assessed, and the impact of imaging modality used on subsequent emergency
room (ER) visits, unplanned procedures, and cost-effectiveness was investigated. Adjusted analyses examined association
between imaging modality used and outcomes, and Markov decision-tree analysis was performed to identify a cost advantageous scenario for ULD-CT over KUB. Of 417 patients studied, 57 (13.7%) underwent ULD-CT while the remaining 360
underwent KUB. The RSF rates were 36.8% and 22.8% in the ULD-CT and KUB groups, respectively (p = 0.019). A 5.6%
and 18% of the patients deemed stone-free on ULD-CT and KUB, respectively, returned to the ER (p = 0.040). Similarly, 2.8%
and 15.1% needed an unplanned surgery (p = 0.027). These findings were confirmed on multivariable analyses, Odds ratios
CT-ULD versus KUB: 0.19 and 0.10, respectively, p < 0.05. With regards to cost-effectiveness, at low ULD-CT charges, the
ULD-CT follow-up pathway was economically more favorable, but with increasing ULD-CT charges, the KUB follow-up
pathway superseded. ULD-CT seems to provide a more ‘true’ estimate of stone-free status, and in consequence mitigates
unwanted emergency and operating room visits by reducing untimely stent removals and false patient reassurances. Further,
at low ULD-CT costs, it may also be economically more favorable.
Keywords Urolithiasis · Urinary stone · Computed tomography · X-ray · Extracorporeal shock-wave lithotripsy
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Shock-wave lithotripsy (SWL) is an outpatient procedure
of low morbidity that offers stone-free rates of 60–90% in
patients with non-lower pole renal stone burden of ≤ 2 cm
or lower pole renal stone burden of ≤ 1 cm [2, 12, 19]. The
American Urological Association and the European Association of Urology guidelines on urinary stone disease list
SWL as a first-line treatment option for these patients [3,
4, 20].
Following SWL treatment, the patients are allowed a
period of 4–6 weeks to pass the stone fragments. At this
point, the patients are re-imaged to assess stone clearance.
Traditionally this has been performed via an abdominal plain
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film, also known as a kidney ureter bladder X-ray (KUB).
However, it is well-recognized that a KUB has limited sensitivity in detecting stones—approximately 60% [7, 9]. This
poor accuracy may lead to untimely removal of an indwelling ureteral stent (if such was used prior or during the SWL
treatment) and/or false patient reassurance, which can lead
to a negative patient outcome. Despite the relatively poor
accuracy, the KUB has remained in use as it is associated
with low radiation exposure (~ 0.7 mSv). For comparison, a
standard abdominal computed tomography (CT) scan with
contrast is associated with a radiation exposure of 10 mSv
[7, 9]. This is not a trivial dose, as malignancies have been
documented at ionizing radiation doses of 100 mSv [5, 18],
and the patients with stone disease are typically young and
often have frequent radiation encounters, either for diagnostic or therapeutic reasons. Thus, imaging modalities that
offer low radiation doses are critical in management of these
patients.
In efforts to reduce radiation exposure, low dose, and
more recently, ultra-low dose imaging protocols have been
developed. A low dose CT is typically associated with a
radiation exposure of ~ 3 mSv, while an ultra-low dose CT
(ULD-CT) is associated with an exposure of ~ 0.5 to 1 mSv
[10, 13–16]. Both protocols have excellent and equivalent
diagnostic accuracies—approximately 95% [13, 16]. An
ULD-CT protocol thus seems to be an ideal imaging method
for stone disease patients as it combines the benefit of computed tomography’s excellent sensitivity, while maintaining
a low radiation exposure.
We undertook the current project to study the utility of
ULD-CT versus KUB as the follow-up imaging in patientsreceiving SWL for upper urinary tract stones. We sought to
compare the stone-free rates in these patients as detected
by KUB versus ULD-CT, and evaluate the implications of
imaging modality used on emergency department visits,
unplanned and planned procedures, and overall cost-effectiveness. We hypothesized that the ULD-CT use would
be associated with more accurate stone-free estimates (at
equivalent radiation exposure as a KUB) and in consequence
reduced unplanned care episodes, but there will be a higher
overall healthcare cost.

Patients and methods
Study population and study time‑period
We performed a retrospective review of electronic medical
charts of patients with upper urinary tract stones who had
undergone SWL at one of two high-volume surgical centers—Henry Ford Hospital, Detroit, MI or Wyandotte Hospital, Wyandotte, MI (January 2013 to December 2016). Both
hospitals utilized Epic medical software to maintain patient
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records (Epic Systems Corporation, WI). Patients included
in this study were selected for SWL per standard guidelines
[3, 4, 20]. Briefly, patients who had an upper urinary tract
stone burden of < 2 cm were given the choice of SWL or ureteroscopy, and outcomes of each technique were explained in
light of the location of the stone, total stone burden, patient
habitus, and stone density. Patients with a BMI > 40 kg/
m2 were not offered SWL. Patients with untreated cardiac
arrythmia, active abdominal aortic aneurysm > 4.5 cm, and/
or on anticoagulation other than Aspirin-81 were also not
offered SWL. Patients who ultimately decided to proceed
with SWL were included in this study (n = 487). The study
was approved by the IRB of the Henry Ford Health System
(IRB number #12450).

SWL technique and follow‑up
A Dornier Lithotripter SII System, which is an electromagnetic lithotripter, was used for SWL. A negative urinalysis or urine culture was mandatory in every patient before
treatment. All procedures were performed on an outpatient
basis and under intravenous anesthesia. Patients with renal
or renal pelvic stones received 2500 [median (IQR): 2360
(2210–2750)] shocks to the afflicting stone while patients
with proximal ureteral stones received 2500–3500 [median
(IQR): 2780 (2100–2990)] shocks, under fluoroscopic and/
or ultrasound guidance. An indwelling ureteral stent at the
time of SWL was placed for a stone burden > 1.5 cm or bilateral urolithiasis. Patients with pre-SWL indwelling ureteral
stent had received it for treatment of a prior acute renal colic
episode. All patients were followed-up for 4–6 months from
the date of surgery. A minimum follow-up of 3 months from
the date of follow-up imaging was necessary to be included
in the study. Patients with insufficient follow-up (n = 49) or
those who required a surgical intervention prior to imaging
(i.e. the time-interval from the SWL treatment but prior to
imaging, n = 21) were excluded. Our final sample size consisted of 417 patients.

Covariates
For each patient, the following clinical parameters were
noted: age, gender, body mass index, renal function,
comorbidities, use of medications that commonly affect
stone formation such as hydrochlorothiazide, furosemide
and anti-epileptics, and whether the patient had a history
of recurrent urinary tract infections. Stone and treatment
characteristics collected included the treatment side, stone
location (renal or proximal ureter), skin-to-stone distance,
stone density in Hounsfield units on the CT scan, diameter
of the largest/targeted stone, whether the patient received a
ureteral stent during/before the procedure, and whether the
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patient received antibiotics during the procedure, and alphablockers at discharge.
The nature of follow-up imaging used was recorded and
the patients were stratified according to it into two groups:
Those undergoing KUB (n = 360) and those receiving
ULD-CT (n = 57). The imaging type ordered was based on
surgeons’ discretion, however, the main factor ultimately
governing the kind of imaging the patient underwent was
insurance authorization, as an ULD-CT was requested in 196
patients, but it was approved in only 57 patients.

Endpoints
A patient was deemed stone-free if radiography, via KUB or
ULD-CT, failed to identify a remaining stone or stone fragment at the site of treatment. The assessment was performed
at 4–6 weeks after surgery by an attending radiologist. To
assess whether follow-up imaging modality has an impact
on further healthcare needs of these patients, co-primary
endpoints comprising emergency department (ED) visits,
unplanned ureteral stent procedures, and planned lithotripsy
procedures (second SWL or ureteroscopy) were assessed.
The former two outcomes were assessed in patients who
were deemed stone-free, with the underlying rationale that if
these patients were truly stone-free, they should not need any
further care with regards to the treated stone. An unplanned
ureteral stent procedure was defined as a need for ureteral
stent on the treated side within 3 months of being deemed
stone-free. Return to emergency room was defined as an ED
visit related to genitourinary symptoms including hematuria,
dysuria, flank pain on the treated side, fevers/chills or nausea/vomiting within 3 months of being deemed stone-free.
The time frame of the assessment was limited to 3 months
from follow-up imaging based on clinical practice patterns,
and a prior study which suggested that beyond 3 months
these patients can have a new renal colic episode [17]. The
need for planned procedures was only assessed in patients
that were not deemed stone-free. We performed this analysis
to ascertain if patients undergoing ULD-CT were receiving
disproportionally more secondary procedures “overtreatment” or not.

Charges for ULD‑CT and KUB
For cost-effectiveness analysis, charge estimates were
obtained via online search of publicly available government repositories, namely Centers for Medicare and Medicaid Service (CMS) reimbursement guide [8], Agency
for care Research and Quality (AHRQ) emergency room
services expenses [1] and online cost calculators (https://
www.fairhe althc onsum er.o rg/). The charges were estimated at: 1. ULD-CT, median 1191$ (range $38–$2000),
2. KUB, median 161$ (range $74–$208), 3. Median

charges of a typical emergency room visit with imaging
and labs: 1265$ + 1191$ + 55$ = 2511$, 4. Medicare reimbursement for the year 2018 for ureteroscopy: 3483$, and
5. Medicare reimbursement for the year 2018 for ureteral
stent placement: 2541$.

Statistical analyses
Descriptive statistics of categorical variables focused on
frequencies and proportions. Medians and interquartile
ranges (IQR) were reported for continuously coded variables. Chi-squared and Mann–Whitney U tests were used
to compare proportions and medians, respectively.
Parsimonious multivariable logistic regression analyses
studied the impact of imaging modality on outcomes. The
models adjusted only for the variables significant in the
univariable analysis (p < 0.05) [6]. For cost-effectiveness
analysis, a simple Markov decision-tree analysis was performed in order to determine the relative cost-effectiveness of ULD-CT versus KUB “pathway”. Given a range
of potential outcomes after the initial imaging including
ED visits and unplanned or planned surgeries, along with
the variances in associated rates and costs of each of these
outcomes, the overall expected cost of each pathway could
be determined for a specific set cost of the initial intervention. Different initial costs of ULD-CT and KUB were
thus examined to analyze the differences in expected overall pathway costs. Three separate cost-average pathways
(low-charge, intermediate-charge, and high-charge) were
generated.
All statistical analyses were performed using the R statistical package (R Foundation for Statistical Computing,
Vienna, Austria), considering a statistical significance at
p < 0.05.

Results
Baseline characteristics
Of the 417 SWL patients studied, 57 (13.7%) underwent
ULD-CT while the remaining 360 (86.3%) underwent
KUB for follow-up imaging. Baseline characteristics of
all patients, stratified by the type of follow-up imaging
modality utilized, are detailed in Table 1. Compared to
patients who underwent KUB, patients who underwent
ULD-CT were more likely to have diabetes mellitus
(38.6% vs 16.4%, p < 0.001), were more likely to be taking hydrochlorothiazide (19.3% vs 7.8%, p = 0.006), and
were less likely to have antibiotics prescribed at the time
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Table 1  Baseline characteristics in patients undergoing shock-wave lithotripsy for upper urinary tract calculi, stratified by the type of follow-up
imaging modality utilized; n = 417 patients (January 2013 to December 2016)
Patient characteristics
Age in year, median (IQR)
Females, n (%)
Body mass index in kg/m2, median (IQR)
Preoperative creatinine in mg/dl, median (IQR)
Comorbidities, n (%)
Diabetes mellitus
Hypertension
Asthma
COPD
Coronary artery disease
Atrial fibrillation
Medications that affect stone formation, n (%)
Hydrochlorothiazide
Furosemide
Anti-epileptics
History of recurrent UTIs, n (%)
Stone characteristics
Treated side [right (remaining left)], n (%)
Stone location [renal (remaining proximal ureter)], n (%)
Multiple stones on the treated side, n (%)
Skin to stone distance in cm, median (IQR)
Stone density in Hounsfield units, median (IQR)
Diameter of largest/treated stone in mm, median (IQR)
Stent (in place or placed during the procedure), n (%)
Antibiotics used during the procedure, n (%)
Alpha-blockers prescribed at discharge, n (%)

KUB group;
n = 360

ULD-CT group;
n = 57

57 (45–61)
128 (35.6)
28.5 (26.5–31.7)
1.03 (0.79–1.25)

62 (44–72)
22 (38.6)
27.0 (25.2–36.3)
0.73 (0.67–1.09)

p value
0.073
0.657
0.977
0.922

59 (16.4)
167 (46.4)
22 (6.1)
33 (9.2)
47 (13.1)
2 (0.6)

22 (38.6)
33 (57.9)
2 (3.5)
7 (12.3)
4 (7.0)
1 (1.8)

< 0.001
0.106
0.433
0.458
0.196
0.320

28 (7.8)
11 (3.1)
0 (0)
42 (11.7)

11 (19.3)
2 (3.5)
0 (0)
2 (3.5)

0.006
0.855
0.999
0.062

162 (45.0)
265 (73.6)
37 (10.3)
13.5 (10.7–14.6)
678.4 (574.1–908.2)
8.0 (6–12.5)
165 (46.0)
312 (86.7)
229 (63.6)

25 (43.9)
43 (75.4)
4 (7.0)
12.1 (10.7–12.9)
714.4 (554.3–971.2)
7.0 (6.3–9.5)
20 (35.1)
35 (61.4)
35 (61.4)

0.872
0.831
0.442
0.439
0.342
0.413
0.125
< 0.001
0.748

49 patients were lost to follow-up and were not included in the analysis
Of note, we could only assess the Hounsfield units for the stones for the patients that had a preoperative
CT [n = 281 for the KUB group, and all patients (n = 57) in the ULD-CT group had a preoperative CT]
KUB kidney ureter bladder X-ray (also called abdominal plain film), ULD-CT ultra-low dose computed tomography scan, UTI urinary tract
infection, IQR interquartile range

of surgical procedure (61.4% vs 86.7%, p < 0.001). Otherwise the groups were well-matched.

Stone‑free rates and univariable outcomes
The stone-free rates were 63.2% (n = 36 of 57) and 77.2%
(n = 278 of 360) in the ULD-CT and KUB groups, respectively (p = 0.019; Fig. 1a).
A 5.6% (n = 2 of 36) of the patients deemed stone-free
on ULD-CT, and an 18% (n = 50 of 278) of patients deemed
stone-free on KUB returned to the ED within 3 months
(p = 0.040) (Fig. 1b). Similarly, 2.8% (n = 1 of 36) of the
patients in the ULD-CT group, compared to 15.1% (n = 42
of 278) of patients in the KUB group needed an unplanned
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surgery (p = 0.027) within 3 months of the follow-up imaging (Fig. 1b).
Of those patients deemed not stone-free, 19.0% (n = 4 of
21) underwent a planned follow-up lithotripsy procedure in
the ULD-CT group, compared to 14.6% (n = 12 of 82) in the
KUB group (Fig. 1c). This difference was not statistically
significant, p = 0.418.

Multivariable adjusted outcomes
Using ULD-CT for follow-up was associated with significantly reduced odds of ED visits and unplanned procedures
in multivariable analyses, with odds ratios (OR) of 0.19

Urolithiasis

Fig. 1  Bar-plots depicting the stone-free rates a, the rates of emergency room (ER) visits and unplanned procedures among the patients
that were deemed stone-free b, and the rate of planned procedures

among the patients that were NOT deemed stone-free c—the study
groups were ultra-low dose computed tomography (ULD-CT) and
kidney ureter bladder X-ray (KUB)

(95% CI 0.04–0.92, p = 0.039) and 0.10 (95% CI 0.01–0.79,
p = 0.030), respectively (Table 2A).
There were no differences in the odds of planned procedures in patients that were not deemed stone-free, OR 1.73
(95% CI 0.44–6.81, p = 0.434; Table 2B).

encounter, and thereby the overall cost-effectiveness of the
ULD-CT versus KUB pathway for a set initial intervention
cost. At low ULD-CT ($382) and KUB ($74) charges, the
ULD-CT follow-up pathway was economically more favorable, but with increasing ULD-CT charges, the KUB followup pathway superseded economically.

Cost‑effectiveness analysis
Significant variation was noted in online-reported ULD-CT
charges ($382 to $2000). Comparatively, charges for KUB
varied from $74 to $208. Figure 2 provides the details on
the probabilities, and charges of each unplanned or planned
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Table 2  (A) Multivariable adjusted odds of experiencing an
unplanned emergency room visit or an unplanned surgery within 3
months in patients deemed stone-free after shock-wave lithotripsy via
ultra-low dose computed tomography scan [reference: kidney ureter
bladder X-ray (KUB)]; n = 314 patients (January 2013 to December
2016) (B) Multivariable adjusted odds of undergoing a planned surgery within 3 months in patients deemed to be NOT stone-free after
shock-wave lithotripsy via ultra-low dose computed tomography scan
[reference: kidney ureter bladder X-ray (KUB)]); n = 103 patients
(January 2013 to December 2016)
Outcomes

(A)
Unplanned emergency
room visit
Unplanned surgery
(B)
Planned surgery

ULD-CT vs KUB (ref.)
Odds

95% confidence
interval

p value

0.19

0.04–0.92

0.039

0.10

0.01–0.79

0.030

1.73

0.44–6.81

0.434

The logistic regression models adjusted for all variable with p < 0.05
in univariable analysis—diabetes mellitus, Hydrochlorothiazide prescription and use of antibiotics during the procedure
KUB kidney ureter bladder X-ray (also called abdominal plain film),
ULD-CT ultra-low dose computed tomography scan

Discussion
SWL accounts for roughly 40% [17] of the 125,000 ambulatory stone surgical procedures performed in the United
States annually, see Tables 9–19 and 9–20 in the cited reference [11]. Follow-up assessment of the stone-free status
in these patients has remained virtually unchanged for the
past 20 years, despite extraordinary advances in imaging.
We undertook this study to determine the benefits, if any,
of utilizing ULD-CT, over KUB, in the follow-up of SWL
treated patients.
The key finding of our study is the demonstration of the
ULD-CT’s ability in reducing the burden of post-imaging
unplanned healthcare encounters in SWL patients. Specifically, we showed that the rates of ED visits within 3 months
of the imaging assessment were 5.6% and 18.0% for the
patients undergoing ULD-CT versus KUB (p = 0.040),
respectively. Similarly, the rates of unplanned surgery in
these patients were 2.8% and 15.1% (p = 0.027), respectively.
It must be emphasized here that the assessment period for
these outcomes was 3 months from the date of postoperative imaging, and not from surgery. Thus we did not capture any adverse events that may have occurred between the
time of surgery and the time of postoperative imaging—this
peculiarity of our study design throws into sharp relief the
divide that exists in terms of adverse events between the two
postoperative imaging pathways. These differences are likely
due to the fact that patients undergoing ULD-CT are more
accurately diagnosed with residual stone fragments versus
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not, and counseled and managed accordingly, avoiding false
patient reassurance, untimely removal of ureteral stents, or
halting of medical expulsive therapy. These data, to the best
of our knowledge, have not been published before, and have
important clinical implications.
From a patient care perspective, use of ULD-CT for
follow-up is undeniably superior as it leads to reduced
unplanned care encounters and procedural morbidity. It is
equally important to look at these data from a healthcareeconomic perspective. If ULD-CT was to be adopted widely,
would it lessen the financial burden of the healthcare? The
answer is yes and no. No, because in the present culture
and at present costs for imaging, adoption of ULD-CT will
only increase the financial toxicity. However, if reforms were
made at the administrative health policy levels to curb and
monotonize the costs of ULD-CT across hospitals, then the
answer could be yes. In line with this, our Markov decisiontree analysis demonstrated that at low-charge for ULD-CT,
this follow-up pathway was economically more superior
to the KUB follow-up pathway. Efforts to promote utilization of ULD-CT following SWL is an actionable change, if
sought after diligently by healthcare leaders and policy makers, and represents a pragmatic opportunity to both improve
patient outcomes and deliver cost-effective care.
Our study also answers the question: what are the ‘true’
stone-free rates in patients undergoing SWL? We found that
the stone-free rates in patients undergoing ULD-CT were
lower, at 63.2%, versus 77.2% for the KUB group, which
is not a surprising finding, given the known superior accuracy of ULD-CT in detection of renal and ureteral calculi,
reported to be close to 95% [13, 16]. On the other hand, the
diagnostic accuracy of a KUB is reported to be about 60%
[7, 9]. Thus, the stone-free rates observed in the ULD-CT
group are likely to be a closer estimation of the ‘true’ stonefree rates, and should be used when counseling patients
regarding the efficacy of SWL.
Our study is not without limitations. First, it is retrospective in nature and thus limited by its inherent design.
However, the data collected were mined from a high-fidelity
electronic database, namely Epic, and there were no fields
of interest (excepting evidence of abnormal renal anatomy)
which had missing data for the patients eligible for the study.
Second, the use of alpha-blockers, antibiotics and ureteral
stenting prior to or during the SWL was not standardized.
This is bound to affect outcomes, however, in general the
providers followed the guidelines laid down by the American
Urological Association [3, 4], as noted in the methods section. Third, only 57 out of the 417 patients underwent ULDCT, leading to a rather small-sized experimental group. This
was due to several reasons: (1) difficulty in obtaining insurance authorization for the ULD-CT imaging due to the paucity of data on this subject—it is difficult to bring about a
change in 20 years of reimbursement and practice patterns
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Fig. 2  A simple Markov decision-tree analysis evaluating the cost-effectiveness of the ULD-CT versus KUB pathway—the study groups were
ultra-low dose computed tomography (ULD-CT) and kidney ureter bladder X-ray (KUB)

without substantial data, and (2) hesitancy on consultant
radiologists’ part to perform the ULD-CT due to reduced
resolution of soft tissues and the associated risk of missing
related pathologies and the medico-legal ramifications of
such. Although the limited sample size in the current study
is a limitation, it does speak to the timeliness and importance of undertaking this study for future patients. Fourth,
79 patients out of the 360 in the KUB study group did not
undergo a preoperative CT scan. Hence, for these patients
we were not able to calculate the skin-to-stone distance and
stone density in Hounsfield units. In these cases, surrogate
markers such as BMI and the ease of stone visibility on
the KUB (a rough indicator of stone hardness) guided the
clinician’s judgment to enroll the patient for SWL. Lastly,
it is possible that certain patients may have had complications but did not present to our institution for management,
and thus the rate of adverse events post-imaging may be

underestimated. This, however, we assume would affect both
groups equally, and would not be an unequal source of bias
on the study findings. Our study is the first of its kind and
should be viewed as an exploratory study. It is often difficult
to undertake prospective studies without preliminary data to
support them (from retrospective studies). Our limitations
listed here thus represent areas for improvement for a future
prospective study.

Conclusions
In conclusion, ULD-CT provides a more ‘true’ estimate of
stone-free status after SWL, and in consequence mitigates
unwanted emergency and operating room visits. Further,
at low ULD-CT costs, it may also be economically more
favorable. Prospective studies are warranted to evaluate
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this question further, and if findings hold true, a health
policy level change in curbing ULD-CT costs may be
needed. The utilization of ULD-CT following SWL thus
represents a unique opportunity to both improve patient
outcomes and deliver cost-conscious care.
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